Abbott wins CE Mark for next-gen Absorb device

Abbott wins CE Mark approval in the European Union for a new delivery catheter for its next-generation Absorb bioabsorbable stent.

Abbott (NYSE:ABT) said today that it won CE Mark approval in the European Union for a next-generation delivery device for its Absorb bioabsorbable coronary stent.

Abbott

News Well, Bioabsorbable Stents, CE Mark, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Hf1cC3